Demographic, clinical, financial factors tied to GLP-1 agonist discontinuation
Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in JAMA Network Open.
May 30, 2024
0
0